|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0000956,
umls-concept:C0003280,
umls-concept:C0004057,
umls-concept:C0007189,
umls-concept:C0010055,
umls-concept:C0012582,
umls-concept:C0027778,
umls-concept:C0031444,
umls-concept:C0035168,
umls-concept:C0175566,
umls-concept:C0205210,
umls-concept:C0226276,
umls-concept:C0439234,
umls-concept:C0439422,
umls-concept:C0439423,
umls-concept:C0442027,
umls-concept:C0445550,
umls-concept:C0741847,
umls-concept:C1257890,
umls-concept:C1272753,
umls-concept:C1274040,
umls-concept:C1280500,
umls-concept:C1527362,
umls-concept:C1708528,
umls-concept:C1947917,
umls-concept:C2603343
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
1994-11-22
|
|
pubmed:abstractText |
This study was performed to compare the efficacy and safety of aspirin, aspirin plus dipyridamole, and oral anticoagulant agents in the prevention of internal mammary artery graft occlusion.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0735-1097
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
1
|
|
pubmed:volume |
24
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1181-8
|
|
pubmed:dateRevised |
2010-3-24
|
|
pubmed:meshHeading |
pubmed-meshheading:7930237-Acenocoumarol,
pubmed-meshheading:7930237-Anticoagulants,
pubmed-meshheading:7930237-Aspirin,
pubmed-meshheading:7930237-Dipyridamole,
pubmed-meshheading:7930237-Double-Blind Method,
pubmed-meshheading:7930237-Drug Therapy, Combination,
pubmed-meshheading:7930237-Female,
pubmed-meshheading:7930237-Graft Occlusion, Vascular,
pubmed-meshheading:7930237-Humans,
pubmed-meshheading:7930237-Internal Mammary-Coronary Artery Anastomosis,
pubmed-meshheading:7930237-Male,
pubmed-meshheading:7930237-Middle Aged,
pubmed-meshheading:7930237-Phenprocoumon,
pubmed-meshheading:7930237-Prospective Studies,
pubmed-meshheading:7930237-Risk Factors,
pubmed-meshheading:7930237-Time Factors,
pubmed-meshheading:7930237-Treatment Outcome,
pubmed-meshheading:7930237-Vascular Patency
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
Effects of low dose aspirin (50 mg/day), low dose aspirin plus dipyridamole, and oral anticoagulant agents after internal mammary artery bypass grafting: patency and clinical outcome at 1 year. CABADAS Research Group of the Interuniversity Cardiology Institute of The Netherlands. Prevention of Coronary Artery Bypass Graft Occlusion by Aspirin, Dipyridamole and Acenocoumarol/Phenprocoumon Study.
|
|
pubmed:affiliation |
Department of Cardiology, University Hospital, Groningen, The Netherlands.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
